2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $405M | $444M | $494M | $523M | $509M |
Cost of Revenue | $276M | $343M | $374M | $375M | $356M |
Gross Profit | $129M | $100M | $120M | $148M | $152M |
Gross Profit % | 32% | 23% | 24% | 28% | 30% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $10M | $4.8M | $21M | $32M | $34M |
Dep. & Amort. | $24M | $28M | $34M | $19M | $19M |
Def. Tax | -$7.4M | -$4.3M | -$5.2M | $4.5M | $344K |
Stock Comp. | $359K | $5.4M | $1.9M | $4.6M | $3.8M |
Chg. in WC | $15M | -$15M | -$815K | -$34M | -$37M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $22M | $58M | $49M | $57M | $63M |
ST Investments | $340K | $731K | $0 | $0 | $0 |
Cash & ST Inv. | $22M | $58M | $49M | $57M | $63M |
Receivables | $58M | $68M | $82M | $92M | $108M |
Inventory | -$64M | $731K | $1 | $6.6M | $0 |
IBEX reported record Q2 FY2025 revenue of $140.7 million, a 6.1% increase year-over-year, driven by strong growth in HealthTech (31%), Travel Transportation and Logistics (17%), and retail and e-commerce (4%), partially offset by a 15% decline in FinTech.
Adjusted EBITDA margin improved by 100 basis points to 11.8%, with adjusted net income rising 20% to $9.6 million and adjusted EPS increasing 36% to $0.59 compared to the prior year.
The company achieved significant wins with its Wave IX AI solutions, including AI Translate and AI Automate, which are driving revenue growth, improving client retention, and enhancing profitability.
IBEX raised its FY2025 guidance, now expecting revenue between $525 million and $535 million (up from $515 million to $525 million) and adjusted EBITDA between $68 million and $69 million (up from $67 million to $69 million).
Strategic initiatives included the repurchase of 3.6 million shares to eliminate controlled company status, board enhancements with AI expertise, and continued investments in higher-margin offshore regions and digital omnichannel services.